These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10548241)

  • 1. Is low-molecular-weight heparin useful for venovenous hemofiltration in the intensive care unit?
    Spiegel DM; Anderson RJ
    Crit Care Med; 1999 Oct; 27(10):2316-7. PubMed ID: 10548241
    [No Abstract]   [Full Text] [Related]  

  • 2. The landscape of thromboprophylaxis utilization in critically ill children: sparse and variable.
    Gist KM; Chima RS
    Crit Care Med; 2014 May; 42(5):1317-8. PubMed ID: 24736356
    [No Abstract]   [Full Text] [Related]  

  • 3. Preventing venous thromboembolism in the intensive care unit: A no-brainer?
    Gould MK
    J Crit Care; 2005 Dec; 20(4):304-5. PubMed ID: 16310598
    [No Abstract]   [Full Text] [Related]  

  • 4. Time to recommend heparin and low-molecular-weight heparins in thromboprophylaxis in medical-surgical critically ill patients.
    Volpi N
    Crit Care Med; 2013 Sep; 41(9):2224-6. PubMed ID: 23979368
    [No Abstract]   [Full Text] [Related]  

  • 5. Heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review and meta-analysis of randomized trials.
    Alhazzani W; Lim W; Jaeschke RZ; Murad MH; Cade J; Cook DJ
    Crit Care Med; 2013 Sep; 41(9):2088-98. PubMed ID: 23782973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous thromboembolism in the ICU and reversal of bleeding on anticoagulants.
    DeLoughery TG
    Crit Care Clin; 2005 Jul; 21(3):497-512. PubMed ID: 15992670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DVT prevention. Low-molecular-weight heparin is a viable option.
    Benton L
    Am J Nurs; 2000 Feb; 100(2):84. PubMed ID: 10712165
    [No Abstract]   [Full Text] [Related]  

  • 8. Anticoagulant prophylaxis in special populations with an indwelling epidural catheter or renal insufficiency.
    Douketis JD; Rabbat C; Crowther MA;
    J Crit Care; 2005 Dec; 20(4):324-9. PubMed ID: 16310603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venous thromboembolism prophylaxis in critically ill patients.
    McLeod AG; Geerts W
    Crit Care Clin; 2011 Oct; 27(4):765-80, v. PubMed ID: 22082513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newer anticoagulants in critically ill patients.
    Rajasekhar A; Beyth R; Crowther MA
    Crit Care Clin; 2012 Jul; 28(3):427-51, vii. PubMed ID: 22713616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strength of evidence for low-molecular-weight heparin.
    Alonso-Ortiz del Rio C; Romero-Alonso A; Marin-Leon I; Rincon-Gomez M
    Chest; 2002 Jun; 121(6):2078; author reply 2078-9. PubMed ID: 12065386
    [No Abstract]   [Full Text] [Related]  

  • 12. [Low Molecular Weight Heparin use in Internal Medicine hospitalized patients].
    Jaras Hernández ; Agudo de Blas P; González Polo J; García Viejo MA; Estellés Piera F; Nieto López-Guerrero J; Noguerado Asensio A; Obón Azuara B; Gutiérrez Cía I; Villanueva Anadón B; Cía Blasco P; Montoiro Allué R; Cárcamo Merino A; Milagros Montero M; Supervía Caparrós A; Gimeno-Bayón Cobos JL; Aguirre Tejedo A; Gutiérrez Cebollada J; López Rodríguez R; Martínez Rey C; Campos Franco J; Alende Sixto MR; Torre Carballada JA; Sánchez Donoso N; Vicente de Vera Floristán C; Peña Porta JM; Pifarré Teixidó R; Benedicto Buendía A; Mingo Santos S; Montero Gaspar MA; Ortiz de Saracho Y Bobo J; Rey Terrón L; Fernández Flores A
    An Med Interna; 2006 Jul; 23(7):347-54. PubMed ID: 17067238
    [No Abstract]   [Full Text] [Related]  

  • 13. A controlled trial of low-molecular-weight heparin (dalteparin) versus unfractionated heparin as anticoagulant during continuous venovenous hemodialysis with filtration.
    Reeves JH; Cumming AR; Gallagher L; O'Brien JL; Santamaria JD
    Crit Care Med; 1999 Oct; 27(10):2224-8. PubMed ID: 10548211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of neuraxial anesthesia in patients receiving perioperative low-molecular-weight heparin for thromboprophylaxis.
    Llau JV
    Chest; 1999 Dec; 116(6):1843-4. PubMed ID: 10593829
    [No Abstract]   [Full Text] [Related]  

  • 15. Advances and contemporary issues in prophylaxis for deep vein thrombosis.
    Hirsh J
    Chest; 2003 Dec; 124(6 Suppl):347S-348S. PubMed ID: 14668416
    [No Abstract]   [Full Text] [Related]  

  • 16. Thromboprophylaxis with low molecular weight heparin versus unfractionated heparin in intensive care patients: a systematic review with meta-analysis and trial sequential analysis.
    Beitland S; Sandven I; Kjærvik LK; Sandset PM; Sunde K; Eken T
    Intensive Care Med; 2015 Jul; 41(7):1209-19. PubMed ID: 25971389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low molecular weight heparin in management and prevention of portal vein thrombosis.
    Lisman T
    Thromb Res; 2014 Oct; 134(4):761-2. PubMed ID: 25179517
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of low-molecular-weight heparins in treating thrombosis.
    Lee AY
    J Support Oncol; 2006 Mar; 4(3):123-4. PubMed ID: 16553137
    [No Abstract]   [Full Text] [Related]  

  • 19. Thromboprophylaxis in the intensive care unit: focus on medical-surgical patients.
    Cook DJ; Crowther MA
    Crit Care Med; 2010 Feb; 38(2 Suppl):S76-82. PubMed ID: 20083918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-molecular-weight heparins for the long-term treatment of cancer patients with venous thromboembolism.
    Prandoni P
    J Support Oncol; 2006 Mar; 4(3):127-8. PubMed ID: 16553138
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.